Related references
Note: Only part of the references are listed.EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer
Vito Amodio et al.
CANCER DISCOVERY (2020)
Gene Expression Signature to Predict Prognosis and Adjuvant Chemosensitivity of Colorectal Cancer Patients
Jianxia Li et al.
CANCER MANAGEMENT AND RESEARCH (2020)
The m6A methylation regulator-based signature for predicting the prognosis of prostate cancer
Jiamin Wang et al.
FUTURE ONCOLOGY (2020)
A novel prognostic signature of immune-related genes for patients with colorectal cancer
Jun Wang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Identification of prognostic immune-related signature predicting the overall survival for colorectal cancer
J. Bai et al.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES (2020)
Comprehensive review of targeted therapy for colorectal cancer
Yuan-Hong Xie et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Macrophage-derived CCL22 promotes an immunosuppressive tumor microenvironment via IL-8 in malignant pleural effusion
Dong Wang et al.
CANCER LETTERS (2019)
VEGF in Signaling and Disease: Beyond Discovery and Development
Rajendra S. Apte et al.
CELL (2019)
RECIST 1.1 for Response Evaluation Apply Not Only to Chemotherapy-Treated Patients But Also to Targeted Cancer Agents: A Pooled Database Analysis
Saskia Litiere et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma
Qian Song et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
FLOT1 promotes tumor development, induces epithelial-mesenchymal transition, and modulates the cell cycle by regulating the Erk/Akt signaling pathway in lung adenocarcinoma
Louqian Zhang et al.
THORACIC CANCER (2019)
M2 macrophages confer resistance to 5-fluorouracil in colorectal cancer through the activation of CCL22/PI3K/AKT signaling
Chen Wei et al.
ONCOTARGETS AND THERAPY (2019)
Immunotherapy of colorectal cancer: Challenges for therapeutic efficacy
Davide Ciardiello et al.
CANCER TREATMENT REVIEWS (2019)
Biomarkers for Predicting Response to Immunotherapy with Immune Checkpoint Inhibitors in Cancer Patients
Michael J. Duffy et al.
CLINICAL CHEMISTRY (2019)
Prognosis in patients with synchronous colorectal cancer metastases after complete resection of the primary tumor and the metastases
Sigmar Stelzner et al.
JOURNAL OF SURGICAL ONCOLOGY (2019)
Targeting Immune-Related Biological Processes in Solid Tumors: We do Need Biomarkers
Fabio Pagni et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Identification of a 6-gene signature predicting prognosis for colorectal cancer
Shuguang Zuo et al.
CANCER CELL INTERNATIONAL (2019)
An Immune-Related Signature Predicts Survival in Patients With Lung Adenocarcinoma
Minghui Zhang et al.
FRONTIERS IN ONCOLOGY (2019)
Prospective Biomarker Study in Advanced RAS Wild-Type Colorectal Cancer: POSIBA Trial (GEMCAD 10-02)
Xabier Garcia-Albeniz et al.
ONCOLOGIST (2019)
Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram Project
Katrin M. Sjoquist et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram Project
Katrin M. Sjoquist et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Nuclear factor I X is a recurrent target for HPV16 insertions in anal carcinomas
Emmanuelle Jeannot et al.
GENES CHROMOSOMES & CANCER (2018)
Drug response to PD-1/PD-L1 blockade: based on biomarkers
Qi Chen et al.
ONCOTARGETS AND THERAPY (2018)
Modeling the prevention of colorectal cancer from the combined impact of host and behavioral risk factors
Matthew Frampton et al.
GENETICS IN MEDICINE (2017)
p38MAPK/MK2-dependent phosphorylation controls cytotoxic RIPK1 signalling in inflammation and infection
Manoj B. Menon et al.
NATURE CELL BIOLOGY (2017)
Does response rate of chemotherapy with molecular target agents correlate with the conversion rate and survival in patients with unresectable colorectal liver metastases?: A systematic review
M. Okuno et al.
EJSO (2017)
Heterogeneity of Programmed Cell Death Ligand 1 Expression in Multifocal Lung Cancer
Aaron S. Mansfield et al.
CLINICAL CANCER RESEARCH (2016)
A 19-Gene expression signature as a predictor of survival in colorectal cancer
Nurul Ainin Abdul Aziz et al.
BMC MEDICAL GENOMICS (2016)
The Role of the IL-20 Subfamily in Glaucoma
Mary K. Wirtz et al.
MEDIATORS OF INFLAMMATION (2016)
Classification and characterization of microsatellite instability across 18 cancer types
Ronald J. Hanse et al.
NATURE MEDICINE (2016)
Changes of immunocytic phenotypes and functions from human colorectal adenomatous stage to cancerous stage: Update
Yanhong Shi et al.
IMMUNOBIOLOGY (2015)
PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
Sandip Pravin Patel et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
Eliezer M. Van Allen et al.
SCIENCE (2015)
The stress-responsive kinases MAPKAPK2/MAPKAPK3 activate starvation-induced autophagy through Beclin 1 phosphorylation
Yongjie Wei et al.
ELIFE (2015)
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Alexandra Snyder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Gene Expression Profiles Accurately Predict Outcome Following Liver Resection in Patients with Metastatic Colorectal Cancer
Hiromichi Ito et al.
PLOS ONE (2013)
ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks
Gabriela Bindea et al.
BIOINFORMATICS (2009)
Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment
Diego O. Croci et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Share Paper
